Celanese

Celanese Corp. engages in the provision of technology and specialty materials businesses. It operates through the following segments: Engineered Materials, Acetate Tow, Acetyl Chain and Other Activities. The Engineered Materials segment includes the engineered materials business, food ingredients business and certain strategic affiliates. The Acetate Tow segment serves consumer-driven applications and is a global producer and supplier of acetate tow and acetate flake used in filter products applications. The Acetyl Chain segment includes the integrated chain of intermediate chemistry, emulsion polymers and ethylene vinyl acetate (EVA) polymers businesses, based on similar products, production processes, classes of customers and selling and distribution practices as well as economic similarities over a normal business cycle. The Other Activities segment consists of corporate center costs, including administrative activities such as finance, information technology and human resource functions, interest income and expenses associated with financing activities. The company was founded by Camille Dreyfus and Henri Dreyfus in 1918 and is headquartered in Irving, TX.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Celanese reports robust Q4 performance, addresses challenges, eyes growth

Celanese's Q4 performance was strong, with a focus on debt reduction and strategic investments. Challenges in the M&M business are being addressed, while opportunities lie in market dynamics and operational enhancements. The company's clear Lake expansion project and cost-saving initiatives position it for future growth.

Celanese reports solid Q1 performance, eyes market recovery opportunities

Celanese's Q1 earnings call highlighted a strong performance with a focus on market recovery and controllable actions. The company faces challenges in slower demand growth but sees opportunities in market trends and synergies.

Celanese faces China demand challenges but anticipates debt reduction success

Celanese navigated challenges in China and the Acetyl Chain, with signs of price movement up despite lower demand. Sequential improvement is expected in 4Q through cost control and synergies. The company is focused on aggressively lowering debt and diversifying distribution channels for growth.

Celanese reports robust Q3 earnings, targets debt reduction and growth

Celanese's Q3 earnings call highlighted strong performance in key segments, with a focus on earnings growth, debt reduction, and market challenges. The company's strengths include flexibility, synergies, and cost optimization strategies, while facing challenges from demand uncertainties and pricing fluctuations. Opportunities for Celanese include strategic expansions, sustainability initiatives, and debt reduction goals for future growth.

Celanese projects strong 2024 performance with focus on synergies

Celanese is poised for strong performance in 2024 with a focus on cost efficiencies and operational synergies.
The company's strategic strengths lie in projected synergies, margin expansion, and deleveraging efforts.
Challenges include past volume losses and reliability issues, but opportunities exist in market growth and operational enhancements.
Overall, Celanese is strategically positioned to navigate market conditions and drive value creation.

Celanese resilient in Q1 amidst market disruptions and growth opportunities

Celanese navigated market disruptions to maintain strong financial performance.
Focus on synergies, controllable actions, and market conditions to meet guidance.
Opportunities lie in consumer confidence, Clear Lake expansion, and cost efficiencies.
Challenges include pricing pressure, market disruptions, and delayed startups in China.

Celanese projects growth in Q3 and Q4 amidst market challenges

Celanese anticipates stable market conditions and growth opportunities in Q3 and Q4 driven by synergy capture and productivity improvements.
Efforts to resolve acetyls force majeure and mitigate pricing pressures on raw materials are ongoing.
The company is focused on maximizing free cash flow efficiency, reducing debt, and adapting to market dynamics for sustained growth.
Evaluation of divestiture opportunities and maintaining a balanced approach in methanol integration are key strategic considerations.

Celanese disappoints in Q3, plans dividend cut for deleveraging

Celanese faces challenges from macroeconomic headwinds, prompting actions to support deleveraging and enhance profitability. The company's focus on cost reduction, synergies, and project pipeline acceleration aims to drive earnings growth. Clear Lake project and ongoing asset optimization present opportunities for value creation.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

DALLAS--(BUSINESS WIRE)--1Q23 NON-GAAP FINANCIAL MEASURES.

Celanese Corporation Reports First Quarter 2023 Earnings

Celanese is faced with headwinds such as slumps in demand and rising costs that shape its performance as well as that of the industry. The company has made acquisitions, increased product prices, and focused on the Western Hemisphere, where there's incremental demand.

Celanese Corporation: Cheap But Risk Bound

Ally Financial

Bank of America

Bank of New York Mellon

Citigroup

Globe Life Inc

General Motors

Jefferies Financial Group Inc

Kraft Heinz

Paramount Global

Taiwan Semiconductor Manufacturing

U.S. Bancorp

This Warren Buffett holdings list from Kiplinger first appeared 2/14/23 online. YCharts and Dogs of The Dow both track this Buffett/Berkshire batch. Here is your update from 4/25/23 YCharts data. 33 of 49 current Berkshire-Hathaway-owned-stocks pay dividends. As of 4/25/23, the top-ten ranged 3.48%-6.04% by annual-yield and 47 of 49 ranged -1.05% to 71.17% per broker-estimated target-price-upsides.

Buy 7 April Buffett Dividend Dogs And Watch 2

Agilent Technologies

ABM Industries

Agree Realty

American Financial Group

American Financial Group Inc 6 1/4 % Debentures 2014-30.9.54 Subord

Alamo Group

American Tower

A. O. Smith

Ames National

Bar Harbor Bankshares

Bank of Montreal

Bristol-Myers

Bank of Nova Scotia

Brady Corporation

Sierra Bancorp

Camden National

Casey's General Stores

City Hld

Clorox

Canadian Imperial Bank of Commerce

Dividend Champion, Contender, And Challenger Highlights: Week Of April 23.

Dividend Champion, Contender, And Challenger Highlights: Week Of April 23

Celanese (CE) gains on cost and productivity actions, investments in high-return projects and contributions of acquisitions.

Celanese (CE) Up 24% in 6 Months: What's Driving the Stock?

Celanese (CE) partners with Glaukos to provide VitalDose for sustained release treatment for glaucoma.

Celanese (CE) & Glaukos Join Forces for Glaucoma Treatment

Warren Buffett's Berkshire Hathaway is known for not worrying too much about near-term market sentiment. This chemicals company has a tremendous long-term future and is very reasonably priced.

2 Warren Buffett Stocks to Buy Now at Absurd Discounts

DALLAS--(BUSINESS WIRE)--Copy Headline of PR

Celanese to Hold First Quarter Earnings Conference Call on May 10, 2023

DALLAS--(BUSINESS WIRE)--Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment

Celanese Announces Agreement with Glaukos Corporation for Sustained Release Glaucoma Treatment

Celanese (CE) forms an alliance with Alessa Therapeutics to develop an innovative drug delivery system for oncology patients.

Celanese (CE) Partners With Alessa for Drug Delivery System

Apple

UPS' transformation has made it highly investable. Celanese keeps improving its underlying margin potential.

3 Warren Buffett Stocks That Are Poised for Major Growth Potential

Celanese (CE) joins forces with Mitsui to form a new Food Ingredient joint venture to strengthen its strategic partnership with the latter.

Celanese (CE) & Mitsui Ink New Partnership, Extend Fairway JV

Arbor Realty Trust

Analog Devices

Automatic Data Processing

American Electric Power Company

Assured Guaranty

Amgen

AMERISAFE

Auburn National Bancorporation

Avient Corp

Atlantica Sustainable Infrastructure

Best Buy

Becton, Dickinson and Co.

Badger Meter

BWX Technologies

Cable One

Cabot

Cogent Communications Holdings

CME Group

Cummins

CNA Financial

Canadian National Railway Company

CNO Financial Group

CRA International

A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends.

Dividend Champion, Contender, And Challenger Highlights: Week Of March 5

DALLAS--(BUSINESS WIRE)---- $CE--Celanese Announces Collaboration with Alessa Therapeutics for the Advancement of Oncology Treatments

Celanese Announces Collaboration with Alessa Therapeutics for the Advancement of Oncology Treatments

DALLAS--(BUSINESS WIRE)---- $CE--Celanese Announces Hytrel® Price Increases

Celanese Announces Hytrel® Price Increases

I've written about, and invested in Celanese for years at this point. This is a BBB-rated specialty chemicals company with a market cap of over $12B. The company has seen declines - where I bought - and upward swings, where I'm taking a more cautious stance on the business.

Celanese Deserves A 2023 Update, And It's A Buy

Celanese Corporation (NYSE:CE ) Q4 2022 Earnings Conference Call February 24, 2023 10:00 AM ET Company Participants Brandon Ayache - VP, IR Lori Ryerkerk - Chairman of the Board and CEO Scott Richardson - CFO Conference Call Participants John McNulty - BMO Capital Markets Ghansham Panjabi - Baird Jeff Zekauskas - JPMorgan Josh Spector - UBS Michael Leithead - Barclays Vincent Andrews - Morgan Stanley Michael Sison - Wells Fargo Hassan Ahmed - Alembic Global P.J. Juvekar - Citi Kevin McCarthy - Vertical Research Partners Frank Mitsch - Fermium Research Matthew DeYoe - Bank of America David Begleiter - Deutsche Bank Jaideep Pandya - On Field Research Operator Hello, and welcome to the Celanese's Q4 2022 Earnings Call and Webcast.

Celanese Corporation (CE) Q4 2022 Earnings Call Transcript

While the top- and bottom-line numbers for Celanese (CE) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Celanese (CE) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates

Celanese (CE) delivered earnings and revenue surprises of -7.69% and 2.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Celanese (CE) Lags Q4 Earnings and Revenue Estimates

DALLAS--(BUSINESS WIRE)--Celanese Corporation (NYSE: CE), a global chemical and specialty materials company, today reported highest-ever GAAP diluted earnings per share of $17.41 and second-highest ever adjusted earnings per share of $15.88 for full year 2022. The Company generated record net sales of $9.7 billion in the year, an increase of 13 percent over the prior record set in 2021.

Celanese Corporation Reports Full Year 2022 and Fourth Quarter Earnings

DALLAS--(BUSINESS WIRE)---- $CE--Celanese and Mitsui & Co., Ltd.

Celanese and Mitsui & Co., Ltd. to Form Food Ingredients Joint Venture; Extend Existing Fairway Methanol LLC Joint Venture

Softness in demand in Europe & Asia, weaker volumes and elevated energy & logistic cost are expected to have put a dent in Celanese's (CE) Q4 performance.

Celanese (CE) to Report Q4 Earnings: What's in the Offing?

DALLAS--(BUSINESS WIRE)---- $CE--Celanese Completes EVA Capacity Expansion at Acetyl Chain Facility in Edmonton

Celanese Completes EVA Capacity Expansion at Acetyl Chain Facility in Edmonton

Capital One

Gildan Activewear

LaZBoy

Williams-Sonoma

Like "awfully good" and "jumbo shrimps," the phrase "cheap compounders" maybe seem like an oxymoron, but they do exist. What is cheap in investing?

5 Cheap Compounders to Consider

Civitas Resources

Comerica

Kohl's

ManpowerGroup

M.D.C. Holdings

Pfizer

QUALCOMM

Tyson Foods

Verizon

It is conventional wisdom that rising interest rates are bad for the stock market, and there is no denying that in 2022 most stock prices fell as interest rates shot up. But John Buckingham, editor of The Prudent Speculator newsletter, points out that periods of rising interest rates are more often correlated with good performance for stocks — especially value stocks.

10 dividend stocks with yields as high as 6.5% from a value manager with a strong track record

News for Celanese Stock (CE)